Sodium hypochlorite is one of 73 small molecule programs targeting Poisoning. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
508 competitors in Atopic Dermatitis
Skyrizi
Cytosar
Fludara
Calcineurin Inhibitors
Sodium hypochlorite
Fucidin
EBGLYSS
Cibinqo
Prograf
Adtralza
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details